Red X iconGreen tick iconYellow tick icon
A postgraduate research opportunity at the University of Otago.


Close date
Tuesday, 28 February 2023
Academic background
Health Sciences
Host campus
PhD, Master's
Pathology (Dunedin)
Dr Heather Cunliffe


The cell surface cytokine receptor Fn14 (TNRFSF12A) and it's cytokine ligand TWEAK, are known to promote malignant progression and reduce survival rates in several solid tumours, including Glioblastoma, and cancers of the breast, kidney, ovary, prostate and esophagus.

Mechanisms leading to aberrant activation of the Fn14/TWEAK signaling axis are poorly understood. Characterising these mechanisms will provide new insight into reducing or halting cellular migration and invasion of Fn14-positive cancers.

This project will investigate genetic, epigenetic, genomic, transcriptomic and cellular factors controlling Fn14/TWEAK expression in laboratory models of malignant progression, and validation studies in archival patient samples.


Dr Heather Cunliffe

Useful information

Similar research opportunities

Back to top